Research article · 4 Jul 2026
Conference abstractPublished 17 Feb 2022
A Perspective on Human Challenges Trials for Vaccines Developments
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A human challenge study is a type of clinical trial for vaccines or other pharmaceuticals that intentionally exposes test subjects (whether or not they have been vaccinated) to the condition being tested. The challenge organism could be any of these: close to wild type and pathogenic; adapted and/or attenuated from its original form with less or no disease symptoms, or genetically modified.When conducting human challenge trials, researchers must consider the value of information and risks to subjects. The trials should be undertaken with ample foresight, attention, and oversight. The trials should be conducted within an ethical framework in which genuinely informed consent is given.Human challenge trials serve as a model for evaluating and representing one possible approach to vaccine development. To protect this vulnerable group, all principles of clinical evaluation should be applied, including the need for approval under a Clinical Trial Authorization (CTA) by the National Regulatory Authorities (NRA) or ethical committees in addition to compliance with Good Clinical Practice (GCP). These trials are often a type of efficacy-indicating study, but most would not be pivotal. Almost all could qualify as a pilot and performed to gain helpful information for vaccine development; several might even occur during vaccine development.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in American Journal of Pharmacology and Pharmacotherapeutics.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Pharmacology and Pharmacotherapeutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nalini Kumari”

